SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Crucell N.V. (CRXL) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (532)1/26/2009 8:37:06 AM
From: kenhott  Read Replies (1) | Respond to of 560
 
<reply> Hindsight is 40/40 (Twice as good as 20/20). Don't forget PFE gets a almost free option on the Alz program. I can hear it now about how very very smart PFE was to take out WYE if the the Alz program works out.



To: kenhott who wrote (532)1/26/2009 10:05:35 AM
From: nigel bates  Read Replies (1) | Respond to of 560
 
Well we now know the minimum price management has set on the company - 20 euros a share:
Message 25356218


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News